
Join to view full profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192
Dr. Picus is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1987 - 1990
Duke University HospitalResidency, Internal Medicine, 1984 - 1987
Harvard Medical SchoolClass of 1984
Certifications & Licensure
MO State Medical License 1991 - 2027
NC State Medical License 1986 - 2026
CA State Medical License 1987 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2014, 2016-2017
Clinical Trials
- Hormone Therapy in Treating Patients With Prostate Cancer
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Publications & Presentations
PubMed
- Evaluating Interim Progression: First PosttherapyLu-PSMA SPECT/CT Relative to Baseline PSMA PET/CT.Ashwin Singh Parihar, Farrokh Dehdashti, Niharika Pant, Shubha G Ravindra, Russell Pachynski
Journal of Nuclear Medicine. 2026-07-23 - Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis.Sandeep Surendra Panikar, Dhruv Bansal, John Crandall, Hari Raman, Joel Picus
International Journal of Molecular Sciences. 2026-06-05 - Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169.Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente, Kristine P Lacuna, Hani M Babiker
Clinical Cancer Research. 2026-05-01
Press Mentions
Defactinib Combined with Pembrolizumab and Gemcitabine in Patients with Advanced CancerApril 18th, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









